Loading...
MERCK Kommanditgesellschaft auf Aktien
MKKGY•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$26.43
$-0.23(-0.86%)
MERCK Kommanditgesellschaft auf Aktien (MKKGY) Financial Performance & Statements
Review MERCK Kommanditgesellschaft auf Aktien’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.78%
↑ 0.78%
Operating Income Growth
1.00%
↑ 1.00%
Net Income Growth
-1.66%
↓ 1.66%
Operating Cash Flow Growth
21.19%
↑ 21.19%
Operating Margin
17.90%
↑ 17.90%
Gross Margin
59.01%
↑ 59.01%
Net Profit Margin
13.13%
↑ 13.13%
ROE
9.68%
↑ 9.68%
ROIC
9.40%
↑ 9.40%
MERCK Kommanditgesellschaft auf Aktien (MKKGY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for MERCK Kommanditgesellschaft auf Aktien stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $5.42B | $5.27B | $5.35B | $5.12B |
Cost of Revenue | $2.32B | $2.12B | $2.12B | $2.11B |
Gross Profit | $3.10B | $3.14B | $3.23B | $3.009B |
Gross Profit Ratio | $0.57 | $0.60 | $0.60 | $0.59 |
R&D Expenses | $527.00M | $524.00M | $647.00M | $581.00M |
SG&A Expenses | $1.05B | $1.41B | $1.43B | $1.35B |
Operating Expenses | $2.27B | $2.05B | $2.07B | $1.94B |
Total Costs & Expenses | $4.59B | $4.17B | $4.56B | $4.05B |
Interest Income | $24.00M | $35.00M | $65.00M | $42.00M |
Interest Expense | $76.00M | $89.00M | $72.00M | $74.00M |
Depreciation & Amortization | $551.00M | $449.00M | $680.00M | $454.00M |
EBITDA | $1.42B | $1.58B | $1.54B | $1.53B |
EBITDA Ratio | $0.26 | $0.30 | $0.29 | $0.30 |
Operating Income | $824.00M | $1.10B | $792.00M | $1.07B |
Operating Income Ratio | $0.15 | $0.21 | $0.15 | $0.21 |
Other Income/Expenses (Net) | -$15.00M | -$54.00M | -$7.00M | -$32.00M |
Income Before Tax | $809.00M | $1.04B | $785.00M | $899.00M |
Income Before Tax Ratio | $0.15 | $0.20 | $0.15 | $0.18 |
Income Tax Expense | $140.00M | $231.00M | $180.00M | $200.00M |
Net Income | $667.00M | $809.00M | $607.00M | $694.00M |
Net Income Ratio | $0.12 | $0.15 | $0.11 | $0.14 |
EPS | $1.53 | $1.86 | $1.40 | $1.60 |
Diluted EPS | $1.53 | $1.86 | $1.40 | $1.60 |
Weighted Avg Shares Outstanding | $434.78M | $434.95M | $434.78M | $434.78M |
Weighted Avg Shares Outstanding (Diluted) | $434.78M | $434.95M | $434.78M | $434.78M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan